Ads
related to: ibb stock price
Search results
The Recent Bullish Trend in IBB, XBI Looks Shaky
ETF.com via Yahoo Finance· 1 year agoThe two biotech ETF products with around $8 billion in assets are IBB and XBI. At $133.36 on February 17, the iShares Biotechnology ETF (IBB) had $8.58...
Zacks Investment Ideas feature highlights: Vertex Pharmaceuticals
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 14, 2022 – Today, Zacks Investment Ideas feature highlights...
Biotech ETF (IBB) Hits New 52-Week High
Zacks via Yahoo Finance· 5 months agoFor investors seeking momentum, iShares Biotechnology ETF IBB is probably on the radar. The fund just hit a 52-week high and is up 25% from its 52-week...
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 16, 2023 – Today, Zacks Investment Ideas feature...
3 Biotech Stocks to Sell Now
InvestorPlace via Yahoo Finance· 2 years agoBiotech stocks have been brought low over the past 18 months. Both the iShares Biotechnology ETF (NASDAQ:IBB) and S&P Biotech ETF (NYSEARCA:XBI), Wall...
7 Best Biotech Stocks To Add to Your Portfolio in 2022
GoBankingRates via AOL· 2 years agoBiotech stocks have a reputation as a moderate- to high-risk investment. That’s because many of...
How Are Biotech ETFs Reacting to Q2 Earnings Releases?
Zacks via Yahoo Finance· 2 years agoThe Biotech sector has been in a sweet spot for quite some time now. Biotech stocks were huge...
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
InvestorPlace via Yahoo Finance· 2 years agoThese are seven of the best stocks to buy that can see substantial returns in the months ahead....
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
InvestorPlace via Yahoo Finance· 3 months agoIf you’re looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ:IBB) is an...
7 Biotech Stocks With Key Catalysts Coming in July
InvestorPlace via Yahoo Finance· 2 years agoBiotech stocks have suffered significant setbacks during the first half of the year. Investors had little appetite for innovation-driven companies,...
